Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.

Ricceri L, De Filippis B, Laviola G.

Behav Pharmacol. 2008 Sep;19(5-6):501-17. doi: 10.1097/FBP.0b013e32830c3645. Review.

PMID:
18690105
2.

Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome.

De Filippis B, Ricceri L, Laviola G.

Genes Brain Behav. 2010 Mar 1;9(2):213-23. doi: 10.1111/j.1601-183X.2009.00551.x. Epub 2009 Nov 2.

3.

Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.

Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM.

Biol Psychiatry. 2006 Mar 1;59(5):468-76. Epub 2005 Sep 30.

PMID:
16199017
4.

Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.

Alvarez-Saavedra M, Sáez MA, Kang D, Zoghbi HY, Young JI.

Hum Mol Genet. 2007 Oct 1;16(19):2315-25. Epub 2007 Jul 17.

PMID:
17635839
5.

Rett syndrome: of girls and mice--lessons for regression in autism.

Glaze DG.

Ment Retard Dev Disabil Res Rev. 2004;10(2):154-8. Review.

PMID:
15362175
6.

The story of Rett syndrome: from clinic to neurobiology.

Chahrour M, Zoghbi HY.

Neuron. 2007 Nov 8;56(3):422-37. Review.

7.

Rett syndrome: new clinical and molecular insights.

Williamson SL, Christodoulou J.

Eur J Hum Genet. 2006 Aug;14(8):896-903. Review.

8.

Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.

Stearns NA, Schaevitz LR, Bowling H, Nag N, Berger UV, Berger-Sweeney J.

Neuroscience. 2007 May 25;146(3):907-21. Epub 2007 Mar 23.

PMID:
17383101
9.

Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.

Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M, Kubota T, Mori H, Tanaka S, Horie H, Tanabe Y, Goto Y.

J Neuropathol Exp Neurol. 2007 Feb;66(2):117-23.

PMID:
17278996
10.

Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.

Belichenko PV, Wright EE, Belichenko NP, Masliah E, Li HH, Mobley WC, Francke U.

J Comp Neurol. 2009 May 20;514(3):240-58. doi: 10.1002/cne.22009.

PMID:
19296534
11.

MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.

Gadalla KK, Bailey ME, Cobb SR.

Biochem J. 2011 Oct 1;439(1):1-14. doi: 10.1042/BJ20110648. Review.

PMID:
21916843
12.

Evidence for abnormal early development in a mouse model of Rett syndrome.

Santos M, Silva-Fernandes A, Oliveira P, Sousa N, Maciel P.

Genes Brain Behav. 2007 Apr;6(3):277-86. Epub 2006 Jul 17.

13.

Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets.

Mantis JG, Fritz CL, Marsh J, Heinrichs SC, Seyfried TN.

Epilepsy Behav. 2009 Jun;15(2):133-41. doi: 10.1016/j.yebeh.2009.02.038. Epub 2009 Feb 26.

PMID:
19249385
14.

Reversal of neurological defects in a mouse model of Rett syndrome.

Guy J, Gan J, Selfridge J, Cobb S, Bird A.

Science. 2007 Feb 23;315(5815):1143-7. Epub 2007 Feb 8.

15.

A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.

Schmid RS, Tsujimoto N, Qu Q, Lei H, Li E, Chen T, Blaustein CS.

Neuroreport. 2008 Mar 5;19(4):393-8. doi: 10.1097/WNR.0b013e3282f5661c.

PMID:
18287934
16.

MeCP2 in neurons: closing in on the causes of Rett syndrome.

Caballero IM, Hendrich B.

Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R19-26. Review. Erratum in: Hum Mol Genet. 2005 Jul 15;14(14):2089.

PMID:
15809268
17.

MeCP2 mutation causes distinguishable phases of acute and chronic defects in synaptogenesis and maintenance, respectively.

Palmer A, Qayumi J, Ronnett G.

Mol Cell Neurosci. 2008 Apr;37(4):794-807. doi: 10.1016/j.mcn.2008.01.005. Epub 2008 Jan 17.

PMID:
18295506
18.

The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Chang Q, Khare G, Dani V, Nelson S, Jaenisch R.

Neuron. 2006 Feb 2;49(3):341-8.

19.

Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.

Filosa S, Pecorelli A, D'Esposito M, Valacchi G, Hajek J.

Free Radic Biol Med. 2015 Nov;88(Pt A):81-90. doi: 10.1016/j.freeradbiomed.2015.04.019. Epub 2015 May 8. Review.

PMID:
25960047
20.

Social impairments in Rett syndrome: characteristics and relationship with clinical severity.

Kaufmann WE, Tierney E, Rohde CA, Suarez-Pedraza MC, Clarke MA, Salorio CF, Bibat G, Bukelis I, Naram D, Lanham DC, Naidu S.

J Intellect Disabil Res. 2012 Mar;56(3):233-47. doi: 10.1111/j.1365-2788.2011.01404.x. Epub 2011 Mar 8.

PMID:
21385260

Supplemental Content

Support Center